{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q13164",
      "entity_text" : "Erk5",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UA-BP-GGP-00072",
      "entity_text" : "Jak",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Furthermore, Jak and Fgfr inhibitors promote primed and naive pluripotency signatures in Erk5 +/+ or Erk5 -/- mESCs (XREF_FIG H), confirming that Erk5 does not modulate transcriptional responses to these key pathways.",
  "reading_complete" : "2020-08-08T13:05:50Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T13:03:08Z",
  "trigger" : "promote",
  "evidence" : [ "Jak and Fgfr inhibitors promote primed and naive pluripotency signatures in Erk5 +/+  or Erk5" ],
  "pmc_id" : "4987282",
  "score" : 0
}